115 related articles for article (PubMed ID: 12182948)
1. Comparative effects of angiotensin IV and two hemorphins on angiotensin-converting enzyme activity.
Fruitier-Arnaudin I; Cohen M; Bordenave S; Sannier F; Piot JM
Peptides; 2002 Aug; 23(8):1465-70. PubMed ID: 12182948
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate.
Zhao Q; Sannier F; Garreau I; Guillochon D; Piot JM
Biochem Biophys Res Commun; 1994 Oct; 204(1):216-23. PubMed ID: 7945362
[TBL] [Abstract][Full Text] [Related]
3. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity.
Lantz I; Glämsta EL; Talbäck L; Nyberg F
FEBS Lett; 1991 Aug; 287(1-2):39-41. PubMed ID: 1652464
[TBL] [Abstract][Full Text] [Related]
4. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition.
Nishiyama A; Seth DM; Navar LG
J Am Soc Nephrol; 2002 Sep; 13(9):2207-12. PubMed ID: 12191964
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
6. Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study.
Ali A; Alzeyoudi SAR; Almutawa SA; Alnajjar AN; Al Dhaheri Y; Vijayan R
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32210030
[TBL] [Abstract][Full Text] [Related]
7. ACE-2/Ang1-7/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats.
Abuohashish HM; Ahmed MM; Sabry D; Khattab MM; Al-Rejaie SS
Biomed Pharmacother; 2017 Aug; 92():58-68. PubMed ID: 28531801
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
9. Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides.
Katwa LC; Tyagi SC; Campbell SE; Lee SJ; Cicila GT; Weber KT
Int J Biochem Cell Biol; 1996 Jul; 28(7):807-21. PubMed ID: 8925411
[TBL] [Abstract][Full Text] [Related]
10. Effect of atrial natriuretic factor on angiotensin converting enzyme.
Kawaguchi H; Sawa H; Yasuda H
J Hypertens; 1990 Aug; 8(8):749-53. PubMed ID: 2170515
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of angiotensin converting enzyme (ACE)-like activity of acellular hemoglobin.
Simoni J; Simoni G; Moeller JF; Tsikouris JP; Wesson DE
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):191-210. PubMed ID: 17453704
[TBL] [Abstract][Full Text] [Related]
12. The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade.
Abuohashish HM; Ahmed MM; Sabry D; Khattab MM; Al-Rejaie SS
Eur J Pharmacol; 2017 Jul; 807():44-55. PubMed ID: 28442323
[TBL] [Abstract][Full Text] [Related]
13. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin.
Zhao Q; Piot JM
Neuropeptides; 1997 Apr; 31(2):147-53. PubMed ID: 9179868
[TBL] [Abstract][Full Text] [Related]
14. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
15. Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N.
Garreau I; Chansel D; Vandermeersch S; Fruitier I; Piot JM; Ardaillou R
Peptides; 1998; 19(8):1339-48. PubMed ID: 9809647
[TBL] [Abstract][Full Text] [Related]
16. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
[TBL] [Abstract][Full Text] [Related]
17. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
[TBL] [Abstract][Full Text] [Related]
18. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
19. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7).
Chappel MC; Ferrario CM
Kidney Int; 2006 Jul; 70(1):8-10. PubMed ID: 16810285
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of the antagonist activity of angiotensin I analogs.
Jackson EK
J Pharmacol Exp Ther; 1992 Jan; 260(1):223-31. PubMed ID: 1731039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
